Alan Merriman
Angel Investor
Dublin, Ireland
Alan Merriman is a Series A investor in Dublin focused on Software and Machine Learning. Alan Merriman is based out of Dublin, Dublin a Co-Founder and Executive Director of Elkstone Capital Partners. Alan previously worked at SHS Capital as a COO. Alan attended the University College Dublin.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Alan Merriman invests in
Stages Alan Merriman invests in
Countries Alan Merriman invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 2 (40%)
- Machine Learning 2 (40%)
- Artificial Intelligence 2 (40%)
- Audio 1 (20%)
- Medical 1 (20%)
Stage
- Series A 4 (80%)
- Seed 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Luminate
|
Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $21M / Series A / Jan 07, 2026 | |
HR Duo
|
We give access to enterprise-level HR services and support. We help manage the entire employment cycle - from onboarding to exit - no matter where in the world your staff are based. We do it through blending the right tech with some of the most experienced HR minds and expertise around. You can automate up to 80% of your HR day-to-day while stayingcompliant, freeing you up to focus on what really matters. It’s like having a team always working away on your behalf, and only a click away. | $4.8M / Series A / Jan 10, 2023 | |
|
Luminate
|
Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $5M / Seed / May 30, 2022 | |
Altada
|
Altada uses artificial intelligence and machine learning to help clients to manage due diligence and regulatory compliance | $11.5M / Series A / Sep 29, 2021 | |
Soapbox Labs
|
SoapBox Labs has developed child-specific speech technology that creates highly accurate, age-appropriate and safe voice-enabled experiences for children. SoapBox Labs' technology is integrated across a range of application areas including toys, gaming, robotics, AR/VR as well as Education (reading and English Language Learning).Technology is fully COPPA and GDPR compliant - offering deep learning speech recognition based online and offline (embedded) solutions in multiple languages. | $6.3M / Series A / Apr 18, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Alan Merriman invest in?
Alan Merriman invests primarily in Software, Machine Learning and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alan Merriman?
Public channels for Alan Merriman include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alan Merriman last invest?
The most recent investment recorded for Alan Merriman closed in Jan 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
